Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty
Clinical trial NCT05493709 · COMPLETED
Trial details
- NCT number
- NCT05493709
- Sponsor
- Foresee Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-02
- Primary completion
- 2025-12-07
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.